Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
H. General Univ. de Alicante, Alicante, Spain
Contact: Study coordinator (Cristina Gil)H. Clínic de Barcelona, Barcelona, Spain
Contact: Study coordinator (Jordi Esteve)H. Vall d' Hebron, Barcelona, Spain
Contact: Study coordinator (Mercedes Gironella)Contact: Principal Investigator (Mercedes Gironella)Hospital del Mar, Barcelona, Spain
Hospital Santa Creu i Sant Pau, Barcelona, Spain
Hospital Universitario Reina Sofía, Córdoba, Spain
Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
Hospital Infanta Leonor, Madrid, Spain
Contact: Principal Investigator (María Ángeles Foncillas, Dr)Hospital Costa del Sol, Marbella, Spain
Hospital Regional Universitario de Málaga, Málaga, Spain
Hospital Universitario Central de Asturias, Oviedo, Spain
H. Son Espases, Palma de Mallorca, Spain
Contact: Study coordinator (Andrés Novo)H. Clínico Univ. de Navarra, Pamplona, Spain
Contact: Study coordinator (José Rifón)H. Clínico Univ. de Salamanca, Salamanca, Spain
Contact: Study coordinator (Jesús Mª Hernández Rivas)Monica Cabrero, MD (Sub-investigator)Hospital Marqués de Valdecilla, Santander, Spain
Hospital Universitario Virgen de Valme, Seville, Spain
H Clínico Universitario Valencia, Valencia, Spain
Contact: Study coordinator (María José Terol Casterá, MD)Complexo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain
Hospital de Vigo, Vigo, Spain
Study leads
Pau Abrisqueta
Principal Investigator
Hospital Universitari Vall d'Hebrón
Francesc Bosch
Principal Investigator
Hospital Universitari Vall d'Hebrón